• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of p38 MAP Kinase in the Regulation of Inflammatory Gene Expression

Research Project

Project/Area Number 17591949
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Functional basic dentistry
Research InstitutionMeikai University

Principal Investigator

OHMORI Yoshihiro  Meikai University, School of Dentistry, 歯学部, 教授 (50194311)

Project Period (FY) 2005 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2006: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2005: ¥2,300,000 (Direct Cost: ¥2,300,000)
KeywordsChemokine / Transcription factor / Phosphorylation / MAP kinase / NF-κB / STAT / LPS / Interferon / interferon
Research Abstract

Lipopolysaccharide (LPS) and interferon gamma (IFNγ) have been show to cooperatively regulate the expression of many macrophage genes such as chemokines. Although the transcriptional regulation of these inflammatory genes has been regulated by transcription factors NF-κB and STAT1, the role of protein kinase induced by LPS and IFNγ in the transcriptional regulation has not been fully understood. In the present study, we performed a series of experiments to determine the functional role of p38 MAP kinase in the transcriptional regulation of the chemokine CXCL9 gene in macrophage cell line RAW264.7 cells, and obtained the following results.
1) To determine whether p38 MAP kinase regulates LPS-induced NF-κB-dependent transcriptional activity, we constructed an expression vector in which NF-κB RelA transactivation domain fused to the GAL4 DNA-binding domain, co-transfected with a luciferase reporter construct containing GAL4 DNA-binding sequences into RAW264.7 cells, and assessed for the lu … More ciferase activity. The results demonstrated that stimulation with LPS enhanced the RelA-dependent transcriptional activity and the enhanced activity was suppressed by SB203580, an inhibitor of p38MAPK.
2) Chromatin immunoprecipitation analysis demonstrated that co-treatment of RAW264.7 cells with IFNγ and LPS cooperatively recruited STAT1, RelA and RNA polymerase II at the promoter region of the CXCL9 gene and that this cooperative recruitment was suppressed by SB203580.
3) Phosphorylation on Ser727 of STAT1 was additively enhanced by co-treatment with LPS and IFNγ, though the magnitude of induction was not synergistic as seen in the transcriptional activity of the CXCL9 gene induced by LPS and IFNγ.
4) Anisomycin, a p38 MAPK activator which enhances Ser727 phosphorylation but has no effect on NF-κB activation, only marginally potentiated IFNγinduced CXCL9 gene expression, suggesting that phosphorylation on Ser727 alone is not sufficient for the synergistic induction of CXCL9 gene.
These results suggest p38MAPK regulates the STAT1- and RelA-mediated enhanceosome formation at the promoter/enhance region of the CXCL9 gene in IFNγ and LPS-stimulated macrophages, which formation then leads to the synergistic transcriptional activity. Less

Report

(3 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • Research Products

    (9 results)

All 2006 2005

All Journal Article (9 results)

  • [Journal Article] Production of chemokine CXCL1/KC by okadaic acid through the nuclear factor-κB pathway2006

    • Author(s)
      Feng, G
    • Journal Title

      Careinogenesis 27

      Pages: 43-52

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Sulindac, a Nonsteroidal Anti-inflammatory Drug, Selectively Inhibits Interferon-γ-induced Expression of the Chemokine CXCL9 Genein Mouse Macrophages2006

    • Author(s)
      Yoshiichi Sakaeda
    • Journal Title

      Biochem Biophys Res Commun. 350・2

      Pages: 339-344

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Product ion of chemokine CXCL1/KC by okadaic acid through the nuclear factor-kappa B patyway.2006

    • Author(s)
      Feng, G., Ohmori, Y., Chang, P-L
    • Journal Title

      Carcinogenesis 27

      Pages: 43-52

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Sulindac, a Nonsteroidal Anti-inflammatory Drug, Selectively Inhibits Interferon-r-induced Expression of the Chemokine CXCL9 Gene in Mouse Macrophages2006

    • Author(s)
      Sakaeda Y, Hiroi M, Shimojima T, Iguchi M, Kanegae H, Ohmori Y
    • Journal Title

      Biochem Biophys Res Commun 350

      Pages: 339-344

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Sulindac, a Nonsteroidal Anti-inflammatory Drug, Selectively Inhibits Interferon- γ -induced Expression of the Chemokine CXCL9 Genein Mouse Macrophages2006

    • Author(s)
      Yoshiichi Sakaeda
    • Journal Title

      Biochem Biophys Res Commun. 350・2

      Pages: 339-344

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Production of chemokine CXCL1/KC by okadaic acid through the nuclear factor-κB pathway.2006

    • Author(s)
      Feng.G
    • Journal Title

      Carcinogenesis 24・1

      Pages: 43-52

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Transcriptional synergism between NF-kB and STAT12005

    • Author(s)
      Hiroi, M
    • Journal Title

      J. Oral Biosciences 47・3

      Pages: 230-242

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Transcriptional synergism between NF-KB and STAT1.2005

    • Author(s)
      Hiroi, M., Ohmori, Y
    • Journal Title

      J. Oral Biosciences 47

      Pages: 230-242

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Transcriptional synergism between NF-κB and STAT1.2005

    • Author(s)
      Hiroi, M
    • Journal Title

      J.Oral Biosciences 47・3

      Pages: 230-242

    • Related Report
      2005 Annual Research Report

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi